切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2012, Vol. 08 ›› Issue (03) : 326 -328. doi: 10.3877/cma.j.issn.1673-5250.2012.03.023

所属专题: 文献

论著

布地奈德混悬液雾化吸入治疗儿童哮喘急性发作的疗效观察
吕有道1,*,*(), 张本金1   
  1. 1. 635000 四川达州,达州市中心医院
  • 收稿日期:2012-02-04 修回日期:2012-05-07 出版日期:2012-06-01
  • 通信作者: 吕有道

Curative Effects of Budesonide Suspension Inhalation on Acute Attack of Asthma in Childhood

You-dao LV1(), Ben-jin ZHANG1   

  1. 1. Department of Pediatrics, Central Hospital of Dazhou, 635000 Dazhou, Sichuan Province, China
  • Received:2012-02-04 Revised:2012-05-07 Published:2012-06-01
  • Corresponding author: You-dao LV
  • About author:
    (Corresponding author: LV You-dao, Email: )
引用本文:

吕有道, 张本金. 布地奈德混悬液雾化吸入治疗儿童哮喘急性发作的疗效观察[J/OL]. 中华妇幼临床医学杂志(电子版), 2012, 08(03): 326-328.

You-dao LV, Ben-jin ZHANG. Curative Effects of Budesonide Suspension Inhalation on Acute Attack of Asthma in Childhood[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2012, 08(03): 326-328.

目的

探讨布地奈德混悬液治疗儿童哮喘急性发作的临床疗效。

方法

选择2011年1月至12月在本院哮喘门诊就诊,并确诊为哮喘急性发作的患儿140例为研究对象。按照就诊顺序,将其随机分为观察组(n=60,布地奈德混悬液+硫酸沙丁胺醇雾化溶液+异丙托溴铵气雾剂雾化吸入治疗)、对照组A(n=40,地塞米松静脉滴注+硫酸沙丁胺醇雾化溶液+异丙托溴铵气雾剂雾化吸入治疗)及对照组B(n=40,单纯静脉滴注地塞米松治疗)。观察用药前、后患儿症状体征,包括呼吸困难、咳嗽、喘息及喘鸣音等改善情况,进行哮喘评分,记录上述症状体征消失时间,并进行相关统计学分析(本研究遵循的程序符合本院人体试验委员会制定的伦理学标准,得到该委员会批准,分组征得受试对象监护人的知情同意,并与其签署临床研究知情同意书)。

结果

治疗后1 h,观察组症状体征改善评分:呼吸困难得分为1.1分、咳嗽为1.1分、喘息为1.4分、喘鸣声为1.4分;对照组A分别为0.9分、0.7分、1.0分及0.9分;观察组症状体征改善评分显著优于对照组A,差异有统计学意义(P<0.05)。观察组呼吸困难消失时间为1.9 d、咳嗽为4.1 d、喘息为3.0 d、喘鸣音为3.6 d;对照组A分别为3.9 d,8.0 d,5.8 d及8.0 d,对照组B分别为4.1 d,8.9 d,6.6 d及7.1 d,观察组较对照组A及对照组B的病程显著缩短,且组间比较,差异均有统计学意义(P<0.05)。

结论

对哮喘急性发作患儿,在雾化吸入支气管扩张剂的同时,加用布地奈德混悬液雾化吸入,对改善症状和缩短病程明显优于静脉滴注地塞米松+雾化吸入支气管扩张剂及单纯静脉滴注地塞米松。

Objective

To discuss curative effects of budesonide suspension inhalation on acute attack of asthma in children.

Methods

From January to December 2011, a total of 140 children who were diagnosed as acute attack of asthma were included into this study. They were divided into three groups according to visiting sequence, observation group (n=60, budesonide suspension inhalation + atomization inhalation of salbutamol sulfate aerosol solution + ipratropium bromide aerosol therapy), control group A (n=40, intravenous infusion of dexamethasone+ atomization inhalation of salbutamol sulfate aerosol solution+ ipratropium bromide aerosol treatment), and control group B (n=40, intravenous infusion of dexamethasone only). The following items were observed, the symptoms before and after the treatment (dyspnea, cough, gasp and wheezing), asthmatic score, and symptom disappearance time. The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Central Hospital of Dazhou. Informed consent was obtained from each participate's parents.

Results

The symptom improvement score after 1 hour of the treatment in observation group and control group A were the following, dyspnea were 1.1, 0.9 score, cough were 1.1, 0.7 score, gasp were 1.4, 1.0 score and wheezing were 1.4, 0.9 score, respectively. And the symptom improvement scores after 1 h of treatment in observation group were better than those in control group A (P<0.05). The symptom disappearance time in observation group and control group A were the following, dyspnea were 1.9 d, 3.9 d, 4.1 d; cough were 4.1 d, 8.0 d, 8.9 d; gasp were 3.0 d, 5.8 d, 6.6 d and wheezing were 3.6 d, 8.0 d, 7.1 d ; respectively. And the course of diseases in observation group were significant shorter than those in control group A and B (P<0.05).

Conclusions

As for children with acute attack of asthma, inhaled bronchodilators combined with budesonide inhalation could improve symptoms and shorten the course of disease, which is significantly better than those treatment programs of intravenous infusion of dexamethasone + inhaled bronchodilators or intravenous infusion of dexamethasone only.

表1 3组哮喘急性发作患儿一般临床资料比较[n(%)]
Table 1 Comparison of general clinical data among 3 groups [n(%)]
表2 3组患儿治疗前及治疗后1 h症状体征改善平均分值比较(分)
Table 2 Comparison of average scores of symptoms and improvement signs before and 1 h after the treatment among 3 groups (score)
表3 3组患儿症状体征消失的平均时间比较(d)
Table 3 Comparison of average time of symptoms and signs disappeared after the treatment among 3 groups(d)
[1]
Soferman R, Glatstein M, Sivan Y, et al. AsGRP levels: Measutememt of airway inflammation in asthmatic children[J]. Pediatr Int, 2008, 122(4):685-688.
[2]
Schneider A, Dinant GJ, Maag I, et al. The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: Results of a diagnostic study in primary care[J]. BMC Fam Pract, 2006, 7:28.
[3]
Holm A, Nexoe J, Bistrup LA, et al. A etiology and prediction of pneumonia in lower respiratory tract infection in primary care[J]. Br J Gen Pract, 2007, 57(540):547-554.
[4]
Moffat M, Cleland J, van der Molen T, et al. Poor communication may impair adherence: Responses to interviews, focus groups, and questionaires[J]. Immuol Allergy Clin North Am, 2005, 25:107-130.
[5]
Respiratory Study Group of Pediatrics Branch of Chinese Medical Association, Editor Borad of Journal of Pediatrics Editorial Committee. Guidelines of bronchial asthma diagnosis and prevention among children[J]. Chin J Pediatr, 2008, 46(10):745-753.
[6]
McMullen A, Yoos HL, Anson E, et al. Asthma care of children in clinical practical do parents report receiving appropriate education[J]. Pediatr Nuts, 2007, 33:37-44.
[7]
Pediatric Asthma Collaborative Group. Conventional prevention and treatment of children with asthma[J]. Chin J Pediatr, 1998, 36(12):747.
[8]
Ducharmem FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children[J]. N Engl J Med, 2009, 360(4):409-410.
[9]
Shapiro G, Mendeflson L, Kraemer MJ. Efficacy and safety of budesonide inhalation suspension (pulmicort respules) in young children with inhaled steroid-dependent, persistent asthma[J]. J Allergy Clin Immunol, 1981, 102(5):789.
[10]
De BJ, Delacourt C, le Bourgeois M, et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study[J]. J Allergy Clin Immunol, 1996, 98:14.
[11]
Shapiro G, Mendeflson L, Kraemer MJ. Efficay and safety of budesonide inhalation suspension (pulmicort respules) in young children with inhaled steroid-dependent, persistent asthma[J]. J Allergy Clin Immunol, 1998, 102(5):789.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 李志文, 李远志, 李华, 方志远. 糖皮质激素治疗膝骨关节炎疗效的网状Meta分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 484-496.
[3] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[4] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[5] 唐丹, 姚晓曦, 杨博文, 薛绍龙, 李梦瑶, 韦柳杏, 郄明蓉. 双肾上腺皮质激素样激酶1对子宫内膜样腺癌患者临床特征的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 582-590.
[6] 王雅楠, 刘丹, 曹正浓, 贾慧敏. 儿童迟发性先天性膈疝患儿的临床诊治特点分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 410-419.
[7] 陈桂华, 钟小玲, 谢雨, 王慧, 谢江, 杨涛毅. 合并肝脏疾病特殊健康状态儿童疫苗预防接种及时性临床分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 431-439.
[8] 刘静, 王燕妮, 王继萍. 儿童毛发移植应用前景及病例讨论[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 368-368.
[9] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[10] 丁荷蓓, 王珣, 陈为国. 七氟烷吸入麻醉与异丙酚静脉麻醉在儿童腹股沟斜疝手术中的应用比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 570-574.
[11] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[12] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[13] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[14] 陈晓胜, 何佳, 刘方, 吴蕊, 杨海涛, 樊晓寒. 直立倾斜试验诱发31 秒心脏停搏的植入心脏起搏器儿童一例并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 488-494.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要